180 Life Sciences Corp. (ATNF)
180 Life Sciences Statistics
Share Statistics
180 Life Sciences has 5.19M shares outstanding. The number of shares has increased by 237.41% in one year.
| Shares Outstanding | 5.19M |
| Shares Change (YoY) | 237.41% |
| Shares Change (QoQ) | 60.7% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 3.63M |
| Failed to Deliver (FTD) Shares | 501 |
| FTD / Avg. Volume | 0.46% |
Short Selling Information
The latest short interest is 139.43K, so 4.39% of the outstanding shares have been sold short.
| Short Interest | 139.43K |
| Short % of Shares Out | 4.39% |
| Short % of Float | 5.17% |
| Short Ratio (days to cover) | 0.03 |
Valuation Ratios
The PE ratio is -0.27 and the forward PE ratio is -3.2. 180 Life Sciences's PEG ratio is 0.
| PE Ratio | -0.27 |
| Forward PE | -3.2 |
| PS Ratio | 0 |
| Forward PS | 0.2 |
| PB Ratio | 0.18 |
| P/FCF Ratio | -1.13 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for 180 Life Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.47 |
| Quick Ratio | 1.47 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.1 |
| Interest Coverage | 124.9 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.54M |
| Employee Count | 4 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -296.02K |
| Effective Tax Rate | 4.58% |
Stock Price Statistics
The stock price has increased by -59.82% in the last 52 weeks. The beta is 0.21, so 180 Life Sciences's price volatility has been higher than the market average.
| Beta | 0.21 |
| 52-Week Price Change | -59.82% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 1.95 |
| Relative Strength Index (RSI) | 29.88 |
| Average Volume (20 Days) | 109.39K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -6.32M |
| Net Income | -6.17M |
| EBITDA | -6.32M |
| EBIT | -6.51M |
| Earnings Per Share (EPS) | -6.74 |
Balance Sheet
The company has 4.59M in cash and 147.89K in debt, giving a net cash position of 4.44M.
| Cash & Cash Equivalents | 4.59M |
| Total Debt | 147.89K |
| Net Cash | 4.44M |
| Retained Earnings | -141.52M |
| Total Assets | 10.47M |
| Working Capital | -5.16M |
Cash Flow
In the last 12 months, operating cash flow was -1.48M and capital expenditures 0, giving a free cash flow of -1.48M.
| Operating Cash Flow | -1.48M |
| Capital Expenditures | 0 |
| Free Cash Flow | -1.48M |
| FCF Per Share | -1.62 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ATNF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Feb 28, 2024. It was a backward split with a ratio of 1:19.
| Last Split Date | Feb 28, 2024 |
| Split Type | backward |
| Split Ratio | 1:19 |
Scores
| Altman Z-Score | -19.15 |
| Piotroski F-Score | 3 |